We recently reported that thymocytes from 6-month-old preleukemic AKR mice express higher levels of murine leukemia virus (MuLV)related antigens than thymocytes from 2-month-old mice. We have now found that the level of xenotropic MuLV (defined operationally as MuLV able'to infect mink cell cultures) is also-markedly increased in thymus of 6-month-old AKR mice and that-this increase in virus correlates closely with increased MuLV-antigen expression. There is no increase of MuLV antigen or xenotropic virus in spleen or lymph nodes. Production of ecotropic MuLV remains unchanged with age in thymus, lymph nodes, and spleen. Thymic grafts from 6-month-old AKR mice, but not from 2-month-old mice, induce both amplified MuLV-antigen expression and xenotropic virus production in the thymus of young AKR recipients. Experiments with lethally irradiated AKR mice reconstituted with syngeneic bone marrow cells indicate that age-related changes in the thymus rather than in bone marrow precursor cells are responsible for MuLV-antigen amplification.
The critical role of the thymus in murine leukemogenesis is well known (1) . In many strains of mice with a high incidence of spontaneous leukemia, the thymus is the first site of recognizable disease, and thymectomy early in life prevents its development (2) . The great majority of such leukemias have T-cell markers (3) , indicating that these cells have undergone some phase of their differentiation in the thymic environment. The etiology of mouse leukemia is complex, with murine leukemia virus (MuLV) (4, 5) , genetic factors that limit or facilitate virus or leukemia cell replication and spread (5, 6) , and humoral factors presumably elaborated by thymic stromal cells (1, 7) each playing a role.
Before the onset of leukemia, characteristic changes occur in the thymus of mice from the high-leukemia AKR strain: (a) the thymic cortex is reduced in size, and structures resembling lymphoid follicles and germinal centers may appear in the medulla (1); (b) the level of adenylate cyclase in the thymus increases (8) ; and (c) the thymocyte undergoes a marked change in the expression of certain cell surface antigens (9, 10) . We have reported recently that starting at about 4-5 months, MuLVrelated antigens (GIx, GCSA, p3O, and gp7O) and H-2 alloantigens on thymocytes show a progressive increase, whereas the differentiation alloantigen Thy-i is reduced (9) .
The present study is a further analysis of the preleukemic changes occurring in AKR mice, with the following questions Abbreviations: MuLV (11, 14) . For (Fig. 2) . The number of cells producing xenotropic virus, however, increased markedly between the second and sixth month; the 2-month thymuses were negative or showed only a rare positive cell, while 6-month thymuses (with one exception) contained large (Fig. 2) . Ecotropic virus production by lymph node and spleen cells was similar in 2-and 6-month-old AKR mice (Table 1) . In contrast to the preleukemic increase in xenotropic virus in thymus, very few cells in the spleen and lymph nodes produced xenotropic virus at either age.
Influence of Thymic Grafts on MuLV-Antigen Expression. Two-month-old AKR recipients received thymus grafts from 2-or 6-month-old syngeneic donors. Fig. 3 shows cytotoxic tests with cells from the recipient's thymus 4-5 weeks after grafting. Expression of MuLV-related antigens on thymocytes was not influenced by thymus grafts from 2-month-old donors, but was amplified by grafts from 6-month-old donors. Grafts of lymph nodes or spleen from 6-month-old AKR donors failed to increase MuLV-antigen expression on thymocytes (data not shown).
To exclude the possibility that cells from the thymic graft simply repopulate the recipient's thymus, experiments were performed with AKR-H-2 mice (24) as donors. AKR-H-2b mice, which differ from AKR at the H-2 locus, undergo the same preleukemic change as AKR in MuLV-antigen expression on thymocytes. Grafts of 6-month-old AKR-H-2b thymus also induced amplified expression of MuLV-antigens in the thymus of 2-month-old AKR mice. Thymocytes from such grafted animals continued to express H-2k antigen characteristic of the AKR recipient, rather than H-2b of the thymic graft donor.
Influence of Thymic Grafts on MuLV Production. The number of cells producing xenotropic virus was markedly increased in the thymus of 2-month-old recipients receiving thymic grafts from 6-month-old donors (Fig. 4) but not from 2-month-old donors. Production of ecotropic virus in the recipient thymus was not affected. Once again, there was a correspondence between the level of xenotropic virus and MuLV-antigen expression in tests on individual thymuses.
MuLV-Antigen Expression in Thymus of Lethally Irradiated AKR Mice Repopulated with Syngeneic Bone Marrow. Two-and six-month-old AKR mice, 1 week after thymic biopsy, were irradiated with 800 R followed by 2 to 4 X 107 bone marrow cells from 2-or 6-month-old AKR donors. Irradiated AKR mice not receiving bone marrow cells died within [8] [9] [10] [11] [12] days, and mice reconstituted with allogeneic bone marrow cells (CBA or C57BL-H-2k) showed replacement of thymus by cells marked by donor Thy-1.2 alloantigen. the expected high expression of MuLV antigens. Thymocytes from 2-month-old mice receiving 6-month-old bone marrow (from donors with amplified thymic MuLV expression) showed sensitivity to anti-NTD identical to that of normal, nonirradiated 2-month-old mice. AKR mice aged 6 months reconstituted with cells from 2-month-old donors retained the characteristically amplified phenotype of 6-month-old thymocytes. Thus, the preleukemic amplification in MuLV-antigen expression on thymocytes appears to be due to age-related changes in the thymus rather than to changes in the bone marrow precursor cell population.
DISCUSSION
It has long been known that morphologic changes occur in the preleukemic AKR thymus which are not seen in other lymphoid tissues (1) . The preleukemic changes in MuLV antigen and virus expression that have now been recognized also appear to be restricted to the primary site of leukemia development-the thymus. As ecotropic virus is generally thought to be the leukemogenic virus of AKR mice, it might be expected that this virus would increase during the preleukemic period and account for the amplified expression of MuLV-related antigens in thymus and for the accelerating effect of cell-free extracts of leukemic and preleukemic thymus on leukemia development in AKR mice (25) (26) (27) . However, no difference in the level of ecotropic virus in 2-and 6-month-old thymus was observed in this study using infectious center assays, or in past studies with titrations of tissue extracts (28 When mice are lethally irradiated and injected with syngeneic bone marrow, the reconstituted thymus is known to be derived from two sources-thymocytes from precursor cells present in the donor bone marrow, and thymic stromal cells (which are radiation resistant) from the original recipient. This has permitted us to analyze which cell population is responsible for the age-related amplification in MuLV-antigen expression that occurs in AKR thymus. As the amplified phenotype is determined by the age of the recipient and not by the age of the bone marrow donor, attention is focused on changes in the properties of the stromal cells. The importance of the thymic stroma in leukemia development has been emphasized by many investigators (1, 7, 26) . With regard to the AKR strain, Law reported (31) that grafts of AKR thymus (from 1-month-old donors; L. W. Law, personal communication, 1976) increased the incidence of leukemia in (C3H X AKR)F1 recipients; grafts of thymus from the low leukemia incidence C3H strain did not. Such thymic grafts rapidly become chimeric, with thymocytes derived from F, cells and thymic stroma from the graft donor.
As a consequence, the leukemias that resulted in F1 mice grafted with AKR thymus were of F1 origi4 as determined by transplantation tests. Law's experiment points to the fact that AKR, but not C3H, stromal cells provide the leukemogenic signal, whether virus, humoral, or otherwise.
The morphological changes in the preleukemic AKR thymus, which include depletion of cortical thymocytes and the appearance of structures resembling lymphoid follicles in the thymic medulla, have suggested to Metcalf (1) that the preleukemic thymus may be the site of an autoimmune reaction which, in some way, initiates the leukemogenic process. (32, 33) , the fact that leukemia cells are selectively destroyed when AKR mice are infused with complement (34) , and the presence of low levels of viral antibody in AKR serum (35, 36) 
